Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M de Miguel Gaztelu"'
Autor:
M De Miguel Gaztelu, T Rubio Vela, S Albás Sorrosal, J Poblet Florentín, I Insausti Gorbea, I Díaz de Santiago
Publikováno v:
Anales del Sistema Sanitario de Navarra. 42:79-82
According to scientific evidence, deep venous thrombosis (DVT) is treated with anticoagulation therapy, involving different periods of time depending on the cause. Occasionally, recurrences appear in the same location, with May-Thurner syndrome or Co
Autor:
I Monteserin Garrastatxu, M Sarobe Carricas, J Polo García, M.E. Carrasco Del Amo, J Preciado Goldaracena, A Agulló Fenoll, M Coma Punset, G Pinilla Lebrero, J Fernández González, JA Illodo Becerra, M de Miguel Gaztelu
Publikováno v:
Eur J Hosp Pharm
Background Treatments for ulcerative colitis (UC) and Crohn’s disease (CD) include conventional agents and tumour necrosis factor-alpha inhibitors (anti-TNFα). A substantial proportion of patients do not respond, are intolerant to both therapies o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e1d772d536dd39870e66f8535fa1e4
https://europepmc.org/articles/PMC7535216/
https://europepmc.org/articles/PMC7535216/
Autor:
M Etxeberria Uriz, Pérez Fernández, S Fernández Peña, R Juanbeltz Zurbano, M de Miguel Gaztelu, B Tirapu Nicolás
Publikováno v:
European Journal of Hospital Pharmacy. 23:A229.1-A229
Background Complementary and alternative medicine (CAM) use has grown considerably, although there is little research about its prevalence in cancer patients in Europe. Purpose The main objective of this study was to determine the prevalence of CAM u
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.